Hair Loss in Women

@article{Harfmann2015HairLI,
  title={Hair Loss in Women},
  author={Katya Harfmann and Mark A. Bechtel},
  journal={Clinical Obstetrics and Gynecology},
  year={2015},
  volume={58},
  pages={185–199}
}
Hair loss is a common cause of morbidity for many women. As a key member of the woman’s health care team, the obstetrician/gynecologist may be the first person to evaluate the complaint of hair loss. Common types of nonscarring hair loss, including female pattern hair loss and telogen effluvium, may be diagnosed and managed by the obstetrician/gynecologist. A systematic approach to diagnosis and management of these common forms of hair loss is presented. 
Primary Care of Adult Women: Common Dermatologic Conditions.
TLDR
An overview of acne, rosacea, melasma, vitiligo, alopecia, nonmelanoma, and melanoma skin cancer, dermatitis, and lichen sclerosus is provided. Expand
5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
TLDR
A proposed low-invasive, sensitive and precise method for the absolute quantification of mRNA levels of aromatase and 5α-R isozymes in plucked hair from young women with FPHL offers a molecular aetiologic diagnosis of FPHL for the selection of more appropriate pharmacological treatments with early predicted effectiveness. Expand
Current advances in stem cell-based therapies for hair regeneration.
TLDR
The up-to-date progress of research efforts focused on stem cell-based therapies for hair regeneration will be discussed, including their therapeutic potentials with respective merits and demerits, as well as the possible mechanisms. Expand
The Genetic Association between Baldness, Coronary Heart Diseases and ABO Blood Group System in Men in Baqubah City-Diyala Province in Iraq
TLDR
People with hereditary baldness may have a predisposition to heart disease compared with people with natural hair, and blood groups distribution may affect indirectly on rates of heart disease difference. Expand
Alopecia androgenetica der Frau
  • G. Lutz
  • Medicine
  • gynäkologie + geburtshilfe
  • 2018
Aufgrund der Vielgestaltigkeit der Ausfallsmuster und der zahlreichen möglichen Ursachen betrachten viele Ärzte Haarausfall als crux medicorum. Doch das Problem ist beherrschbar. Wichtig ist, zuExpand
Alopecia androgenetica der Frau
  • G. Lutz
  • Medicine
  • ästhetische dermatologie & kosmetologie
  • 2018
ZusammenfassungAufgrund der Vielgestaltigkeit der Ausfallsmuster und der zahlreichen möglichen Ursachen betrachten viele Ärzte Haarausfall bei Frauen als crux medicorum. Doch das Problem istExpand
Vulnerable consumer engagement: How corporate social media can facilitate the replenishment of depleted resources
Abstract Technology may facilitate health and wellbeing consumer engagement. When there is scant public health provision and socio-cultural norms marginalize consumers stigmatized from cancer, weExpand

References

SHOWING 1-10 OF 53 REFERENCES
Drugs and hair loss.
Hair loss is a common complaint, both in men and women, and use of prescription medications is widespread. When there is a temporal association between the onset of hair loss and commencement of aExpand
How to diagnose hair loss.
TLDR
This review presents a systematic approach to the diagnosis of hair loss, based on history, clinical examination, laboratory tests, and scalp biopsy, which confirms a diagnosis of cicatricial alopecia. Expand
Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment.
TLDR
Female pattern hair loss is the most common cause of alopecia in women and there is an important adjuvant role for nutritional supplements, light therapy, and hair transplants. Expand
Diffuse female hair loss: are androgens necessary?
TLDR
The case of a young woman with hypopituitarism who presented with the clinical and histological features of female androgenetic alopecia in the absence of detectable levels of circulating androgens or other signs of postpubertal androgenization is reported, showing that this pattern of hair loss is not necessarily androgen dependent. Expand
Female pattern alopecia: current perspectives
TLDR
Current perspectives on therapeutic options for female pattern hair loss are reviewed, with the aim of therapy being to slow or stop disease progression with contentment despite patient expectations of permanent hair regrowth. Expand
Approach to office visits for hair loss in women.
TLDR
For most dermatologists, the trick to handling patients with hair loss is to assess them physically and emotionally to their satisfaction without spending an inordinate amount of time on the visit. Expand
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
TLDR
Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgens receptor antagonists spironolactone and cyproterone acetate, the 5α‐reductase inhibitor finasteride and the androgen‐independent hair growth stimulator minoxidil. Expand
Female pattern hair loss in complete androgen insensitivity syndrome
TLDR
Female pattern hair loss occurring in a patient with complete androgen insensitivity syndrome is described suggesting that mechanisms other than direct androgen action contribute to this common form of hair loss in women. Expand
Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
  • D. Whiting
  • Medicine
  • Journal of the American Academy of Dermatology
  • 1996
TLDR
CTE, which usually affects 30- to 60-year-old women, starts abruptly with or without a recognizable initiating factor and may be distinguished from classic acute telogen effluvium by its long fluctuating course and from AGA by its clinical and histologic findings. Expand
A novel cosmetic approach to treat thinning hair
TLDR
Fibre diameter is another key contributor to thinning hair, but it is less often the focus of medical or cosmetic treatments. Expand
...
1
2
3
4
5
...